Literature DB >> 18086318

A wise nurse can manage a paper protocol but prefers intelligent technology.

Mathijs Vogelzang, Felix Zijlstra, Maarten W N Nijsten.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 18086318      PMCID: PMC2246203          DOI: 10.1186/cc6169

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

We were surprised to read the letter "Tight glycaemic control: intelligent technology or a nurse-wise strategy?" by de Graaff and colleagues [1]. In this letter, the use of complex protocols for tight glucose control is questioned, and a strategy as used in Leuven is proposed: based on nurses' experience, guided with only a few very simple guidelines. Glucose control is not simple but complex. This complexity is underscored by major problems that have been encountered with respect to safety and efficiency. Many factors are known to influence glucose control. Standardizing glucose control has been found to improve both safety and the efficiency of glucose control [2]. Moreover, results obtained with unstandardized treatment protocols as proposed by de Graaff et al. should be interpreted with great caution, as the exact characteristics of the therapy are unknown. We agree with de Graaff et al. that paper protocols can become too complex and may result in bad compliance, efficiency and safety. Computer protocols are generally easy to follow and require fewer glucose measurements than paper-based protocols [3-5]. In our own three-year experience, nurses – both novice and experienced – are very pleased with the efficient process a computer provides. Still, we also value wise nurses and allow our computer protocol to be overridden when needed. Abandoning advanced standardized therapy in favor of relying on human decision-making would clearly be a step backward in our view. The current "5 million lives campaign" by the Institute for Healthcare Improvement calls for a 50% reduction of harm related to high-alert medications (including insulin) focusing on standardization strategies to reduce the chance of human error [6]. In our opinion, a computer program recommending an insulin level, and seeing to it that glucose gets checked in time is the most standardized, effortless, safe and efficient form of glucose control currently available.

Competing interests

The authors declare that they have no competing interests.
  6 in total

1.  Preventing harm from high-alert medications.

Authors:  Frank Federico
Journal:  Jt Comm J Qual Patient Saf       Date:  2007-09

2.  Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation.

Authors:  Emmy Rood; Robert Jan Bosman; Johan Ids van der Spoel; Paul Taylor; Durk Freark Zandstra
Journal:  J Am Med Inform Assoc       Date:  2004-11-23       Impact factor: 4.497

3.  Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial.

Authors:  Roman Hovorka; Jaromir Kremen; Jan Blaha; Michal Matias; Katerina Anderlova; Lenka Bosanska; Tomas Roubicek; Malgorzata E Wilinska; Ludovic J Chassin; Stepan Svacina; Martin Haluzik
Journal:  J Clin Endocrinol Metab       Date:  2007-06-05       Impact factor: 5.958

4.  Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults.

Authors:  Salmaan Kanji; Avinder Singh; Michael Tierney; Hilary Meggison; Lauralyn McIntyre; Paul C Hebert
Journal:  Intensive Care Med       Date:  2004-03-20       Impact factor: 17.440

5.  Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit.

Authors:  Mathijs Vogelzang; Felix Zijlstra; Maarten W N Nijsten
Journal:  BMC Med Inform Decis Mak       Date:  2005-12-19       Impact factor: 2.796

6.  Tight glycaemic control: intelligent technology or a nurse-wise strategy?

Authors:  Mart J de Graaff; Peter E Spronk; Marcus J Schultz
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.